The ASX inched higher on Thursday as gold miners glittered, techs found buyers, Liontown’s lithium deal shrank, and Lynas climbed again.
Drug developers today have released a slew of announcements updating their programs – and the message is slow but steady progress.
Final data from Dimerix’s PARASOL collaboration reinforce proteinuria-based endpoints in its phase III ACTION3 trial of lead drug DMX-200 in FSGS.
Hundreds of Australian authors, including Trent Dalton, Helen Garner and Julia Baird, are set to receive $4500 a book from a $2.2bn AI copyright settlement.
Altech Batteries’ Silumina Anodes boost lithium-ion battery energy density and lifespan, marking major step toward longer-lasting EV power.
